For more than two decades, U.S. health assistance—particularly through PEPFAR—has played a major role in Nigeria’s fight against HIV, tuberculosis, malaria, and other infectious diseases. Millions of Nigerians have accessed lifesaving treatment, health workers have been trained and paid, and surveillance systems strengthened. These contributions deserve recognition.
However, the newly announced America First Global Health Strategy (2025) represents a significant shift in how U.S. health assistance will operate going forward.
For Nigeria, Africa’s most populous nation and one of the largest recipients of U.S. health aid, this strategy raises important questions that demand sober reflection, not emotional reaction.
A Shift from Partnership to Strategic Interest:
The new strategy is explicit: U.S. health assistance is now primarily designed to serve American national security, economic, and geopolitical interests. Saving lives remains important—but it is no longer the central motivation.
Health aid is now framed as a tool to:
<span;><span;>- Prevent outbreaks from reaching U.S. borders
<span;><span;>- Strengthen U.S. geopolitical influence, especially in Africa
<span;><span;>- Expand markets for American pharmaceutical and health technology companies
This framing matters, because it shapes how assistance will be delivered, monitored, and withdrawn.
What Nigeria Could Gain:
Nigeria should not dismiss the strategy outright. There are real potential benefits.
1. Short-term protection of critical services
The U.S. commits to maintaining full funding for frontline health commodities and health workers, at least initially. For Nigeria’s HIV, TB, and malaria programs, this could help prevent sudden service disruptions.
2. Reduced waste and duplication
The strategy acknowledges what Nigerian policymakers have long known: the aid system is bloated. Too much money goes to overhead, consultants, and parallel NGO structures. Streamlining could improve efficiency and strengthen government leadership.
3. Improved outbreak detection and response
Investments in laboratories, disease surveillance, and rapid response systems could help Nigeria detect and control outbreaks faster—protecting lives and economic stability.
The Strategic Risks Nigeria Must Not Ignore:
At the same time, the implications for Nigeria’s sovereignty, fiscal stability, and long-term health security are profound.
1. Conditionality and loss of policy autonomy
Under the new bilateral agreements, U.S. funding will be tied to performance benchmarks, co-financing commitments, and compliance requirements. If Nigeria fails to meet them, the U.S. reserves the right to withhold future funding.
This shifts accountability away from Nigerian citizens and institutions toward external actors.
2. Health data and biological sovereignty
Nigeria will be required to share real-time surveillance data and integrate systems that ensure long-term U.S. access. While justified as “global health security,” this raises concerns about:
Ownership of Nigerian health data
<span;><span;>- Control over pathogen samples
<span;><span;>- Use of Nigerian biological information for external research or commercial benefit
These are not hypothetical concerns; they go to the heart of national sovereignty.
3. A looming fiscal cliff
Nigeria will be expected to progressively absorb costs currently covered by donors—health worker salaries, commodities, and systems—despite:
<span;><span;>- Persistent revenue constraints
<span;><span;>- Competing national priorities
<span;><span;>- Existing debt pressures
If the transition timeline is unrealistic, essential health services could be placed at risk.
4. Commercial dominance over local capacity
The strategy explicitly promotes American pharmaceutical and diagnostic companies. Without safeguards, this could undermine Nigeria’s growing pharmaceutical sector and weaken local manufacturing ambitions.
Health aid should not become a vehicle for market capture at the expense of domestic industry.
5. Health aid as geopolitical leverage
Nigeria may face subtle pressure to align politically in an increasingly competitive global environment. Health assistance should never become a tool to constrain Nigeria’s diplomatic independence or strategic partnerships.
What Nigerian Leaders Should Do:
This moment calls for strategic engagement, not passive acceptance.
1. Negotiate firmly and transparently
Any bilateral agreement must align with Nigeria’s National Health Policy and National Development Plan not external timelines.
2. Protect data sovereignty
Clear legal and ethical frameworks must govern data sharing, sample ownership, and secondary use.
3. Set realistic co-financing paths
Nigeria should not accept transition timelines that risk service collapse.
4. Safeguard local industry
Procurement policies must support Nigerian pharmaceutical manufacturers and regional value chains.
5. Engage regionally
Nigeria should work through Africa CDC, ECOWAS, and the African Union to avoid fragmented, country-by-country concessions.
A Final Word:
Nigeria is no longer merely a recipient of global health aid—it is a pillar of African and global health security. Any partnership must reflect that reality.
The America First Global Health Strategy is a signal of changing global dynamics. Whether it becomes an opportunity for mutual benefit or a new form of dependency will depend on Nigeria’s leadership, negotiation strength, and clarity of vision.
This is not a moment for silence.
It is a moment for informed, confident, and collective engagement.
Muhammad Saddiq
